Global Cervical Dysplasia Market (2021 to 2028) - Share, Size, Trends and Industry Analysis Report -

·3 min read

The "Cervical Dysplasia Market Share, Size, Trends, Industry Analysis Report, By Type; By End-Use, By Regions; Segment Forecast, 2021 - 2028" report has been added to's offering.

The global cervical dysplasia market size is expected to reach USD 936.4 million by 2028 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of cervical cancer and awareness regarding its early diagnosis is the key cervical dysplasia industry impacting factors. As per the report published by World Health Organization, in 2018, worldwide there were around 5, 70,000 new cases of cervical cancer, and more than 3,11,000 deaths were recorded. It also reported that HPV is the most common causal factor for cervical dysplasia among women.

Moreover, Cervical Awareness Month was introduced by the U.S. Congress, in 2019, to declare the month of January dedicated to the patients suffering from cervical cancer in the market. National Cervical Cancer Coalition under government control was responsible to highlight issues related to disease and the importance of early diagnosis. These government-supported initiatives are bound to increase awareness regarding disease screening and are anticipated to boost the market growth for cervical dysplasia.

Companies Mentioned

  • Qiagen N.V.

  • Abbott Laboratories

  • Hologic Inc.

  • Quest Diagnostics

  • DYSIS Medical Ltd

  • Micromedic Technologies Ltd.

  • OncoHealth Corporation Inc.

  • CooperSurgical Inc.

  • Roche

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Research Methodology

4. Cervical Dysplasia Market Insights

4.1. Cervical Dysplasia - Industry snapshot

4.2. Cervical Dysplasia Market Dynamics

4.3. Porter's Five Forces Analysis

4.4. PESTLE Analysis

4.5. Cervical Dysplasia Market Industry trends

5. Cervical Dysplasia Market Assessment by Type

5.1. Key Findings

5.2. Introduction

5.3. Diagnostic Tests

5.4. Diagnostic Devices

5.5. Colposcope

6. Global Cervical Dysplasia Market, by End-Use

6.1. Key Findings

6.2. Introduction

6.3. Hospitals

6.4. Diagnostic Centers

6.5. Ambulatory Surgical Centers

7. Cervical Dysplasia Market Assessment by Geography

7.1. Key findings

7.2. Introduction

7.3. Cervical Dysplasia Market - North America

7.4. Cervical Dysplasia Market - Europe

7.5. Cervical Dysplasia Market - Asia-Pacific

7.6. Cervical Dysplasia Market - Middle East & Africa

7.7. Cervical Dysplasia Market - Latin America

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis

8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Qiagen N.V.

9.2. Abbott Laboratories

9.3. Hologic, Inc.

9.4. Quest Diagnostics

9.5. DYSIS Medical Ltd.

9.6. Micromedic Technologies Ltd.

9.7. OncoHealth Corporation, Inc.

9.8. CooperSurgical Inc.

9.9. Roche

9.10. Karl Kaps GmbH & Co. KG

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting